Trump’s VA Secretary Proud of Psychedelics Research Progress

VA Secretary Doug Collins is making waves by doubling down on his support for psychedelic research to help veterans battling PTSD and TBI. In a recent interview, Collins highlighted the "phenomenal" potential of MDMA-assisted therapy and pushed back against rumors of research cuts, clarifying that studies are simply rotating or finding new funding avenues. With around a dozen active projects within the VA, the administration seems serious about exploring substances like MDMA, psilocybin, and ibogaine. HHS Secretary RFK Jr. has even hinted at a 12-month goal for legal veteran access.

For the cannabis and plant medicine community, this is a massive win. Seeing high-level officials embrace "alternative" therapies validates what many in the culture have known for years: these plants and compounds are medicine. If the VA leads the way, it paves a smoother path for broader legalization and better accessibility for everyone. It’s a refreshing shift toward a more compassionate, science-first approach that prioritizes healing over outdated stigmas.